Serratiopeptidase should be given with caution to patients with coagulation abnormalities, severe hepatic or renal impairment, or those under treatment with anticoagulants. Patients should be under careful observation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education